ACTCELLS Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for ACTCELLS with the United States Patent and Trademark Office. The USPTO has given the ACTCELLS trademark a serial number of 86897753. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 15, 2019. This trademark is owned by Animal Cell Therapies, Inc.. The ACTCELLS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research services in the field of animal stem cells for research, diagnostic, and clinical use; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; all the foregoing for non-human use
actcells

General Information

Serial Number86897753
Word MarkACTCELLS
Filing DateThursday, February 4, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 15, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2017

Trademark Statements

Goods and ServicesMedical and scientific research services in the field of animal stem cells for research, diagnostic, and clinical use; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; all the foregoing for non-human use
Pseudo MarkACT CELLS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 10, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnimal Cell Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121, CA 92121
Party NameAnimal Cell Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121, CA 92121

Trademark Events

Event DateEvent Description
Monday, April 15, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 15, 2019ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 10, 2018EXTENSION 3 GRANTED
Monday, September 10, 2018EXTENSION 3 FILED
Monday, September 10, 2018TEAS EXTENSION RECEIVED
Friday, March 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 14, 2018EXTENSION 2 GRANTED
Wednesday, March 14, 2018EXTENSION 2 FILED
Wednesday, March 14, 2018TEAS EXTENSION RECEIVED
Tuesday, September 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2017EXTENSION 1 GRANTED
Wednesday, September 13, 2017EXTENSION 1 FILED
Monday, September 25, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 13, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 17, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 14, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 3, 2016NON-FINAL ACTION E-MAILED
Friday, June 3, 2016NON-FINAL ACTION WRITTEN
Thursday, May 19, 2016ASSIGNED TO EXAMINER
Thursday, February 11, 2016NOTICE OF PSEUDO MARK E-MAILED
Wednesday, February 10, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

actcells research services stem development fields biotechnology disorders injuries pharmaceutical consulting